SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Rithm Capital Corp. engages in the provision of real estate, credit, and financial services. It operates through the following segments: Origination and Servicing, Investment Portfolio, Residential Transitional Lending, Asset Management, and Corporate. The Origination and Servicing segment includes residential mortgage loans underlying mortgage servicing right assets as well as those sub-service for third parties. The Investment Portfolio segment consists of residential mortgage loans, SFR properties, consumer loans, Non-Agency RMBS, Excess MSRs and servicer advance investments. The Residential Transitional Lending segment competes for both experienced sponsors, including developers and investors in residential real estate, and attractive lending opportunities based on several factors. The Asset Management segment focuses on the wholly owned subsidiaries, Sculptor, and RCM Manager. The company was founded on September 26, 2011 and is headquartered in New York, NY.

Rithm Capital Corporation

Rithm Capital is trending as investors weigh its aggressive expansion strategy, including the pending acquisition of Paramount Group, against ongoing concerns about the company's complex transition from a mortgage REIT to a diversified asset manager. The community remains heavily focused on potential valuation catalysts, such as a possible spin-off of the NewRez mortgage business, while debating whether current share price volatility represents a buying opportunity or a warning sign regarding future dividend growth.

QXO, Inc. is a publicly traded distributor of roofing, waterproofing and complementary building products in the United States. It plans to become tech-enabled in the building products distribution industry and generate outsized value for shareholders. The company was founded on October 3, 2002, and is headquartered in Greenwich, CT.

QXO Inc.

QXO is experiencing significant volatility and downward pressure as investors weigh recent acquisition activity against broader macroeconomic headwinds, including geopolitical tensions and fluctuating construction market sentiment. Despite the bearish pressure, the community remains actively divided, with many long-term shareholders continuing to express confidence in CEO Brad Jacobs' consolidation strategy while others closely monitor for the next M&A catalyst or integration updates.

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

TSLA is under significant downward pressure as investors rotate out of growth stocks amid geopolitical instability and skepticism regarding the execution of its latest AI and infrastructure initiatives. The community remains deeply divided, with some buyers viewing the current price action as a long-term accumulation opportunity, while others express frustration over the stock's recent technical breakdown and the company's dependency on speculative future projects.

Fundrise Innovation Fund LLC. - Common Shares of Limited Liability Company Interests

Fundrise Innovation Fund 

VCX is experiencing significant volatility and price appreciation following its recent NYSE listing, with investors actively debating whether the high premium over its reported net asset value is justified by its exclusive exposure to high-profile private AI companies like Anthropic and OpenAI. Community discussion is dominated by the impact of a mandatory six-month lockup period on the majority of shares, which has created a tight float and sparked intense speculation about potential for further momentum or a sharp correction.

EOG Resources, Inc. engages in the exploration, development, production and marketing of crude oil and natural gas. It operates through the United States, Trinidad, and Other International geographical segments. The Other International segment includes China and Canada operations. The company was founded in 1985 and is headquartered in Houston, TX.

EOG Resources, Inc.

EOG Resources is trending as investors weigh strong production efficiency and a robust capital return strategy against global geopolitical volatility and fluctuating commodity prices. The community is actively discussing the stock's long-term valuation potential and its positioning relative to broader energy sector movements and supply dynamics.

Jupiter is a cryptocurrency exchange platform on the Solana blockchain, offering features such as token swapping, limit orders, dollar-cost averaging, and a bridge for asset transfers to Solana. It provides users with tools to find the best trading prices and includes a beta version for perpetual futures trading. Jupiter finds the best price route for your swap by aggregating all the major liquidity sources on Solana.

Jupiter

Jupiter is capturing significant market attention as users actively engage with its updated lending protocol, allowing them to borrow against staked SOL while simultaneously participating in its broader ecosystem of meme tokens and community-verified projects. Discussions are currently dominated by high APY lending opportunities and the ongoing expansion of its verified token list, fueling diverse sentiment ranging from strong platform loyalty to speculative debates over its long-term tokenomics.

ASML Holding NV engages in the development, production, marketing, sales, upgrading and servicing of advanced semiconductor equipment systems. It includes lithography, metrology and inspection systems. The company was founded on April 1, 1984 and is headquartered in Veldhoven, the Netherlands.

ASML Holding NV - New York Shares

ASML Holding NV

ASML is trending as investors digest a massive Q4 booking report that significantly exceeded expectations, signaling robust long-term demand for AI-driven lithography equipment. Community discussion remains heavily focused on the company's unassailable moat as a 'foundational' AI player, with many traders debating the sustainability of current valuation highs despite strong buyback announcements and increased backlog visibility.

Corvus Pharmaceuticals, Inc. engages in the development of immune modulator product candidates with the potential to treat solid cancers, T-cell lymphomas, autoimmune diseases, and infectious diseases. Its product pipeline includes B Cell Activator and Anti-CD73, Adenosine Production Inhibitor Anti-CD73, ITK Inhibitor, A2AR Inhibitor, Anti-CXCR2, and A2BR Inhibitor. The company was founded by Richard A. Miller, Peter A. Thompson, Joseph J. Buggy, and Erik Verner on January 27, 2014 and is headquartered in South San Francisco, CA.

Corvus Pharmaceuticals Inc

Corvus Pharmaceuticals is currently a focal point for investors following an upsized public offering and clinical trial data for soquelitinib, with community sentiment split between bulls anticipating a potential buyout or short squeeze and bears raising concerns regarding dilution and long-term valuation. Discussion is dominated by the company's capital raise and the speculative potential of its pipeline in treating atopic dermatitis.

Harvest Portfolios Group Inc - Harvest Diversified High Income Shares ETF (Class A Units)

Investors are actively debating the merits of Harvest Diversified High Income Shares ETF, frequently highlighting it as a core component for income-focused portfolios and tax-efficient strategies within Canadian tax-advantaged accounts. While some community members view market dips as opportunities for accumulation, others are engaged in broader discussions regarding the performance of its underlying covered call strategy and its role in long-term wealth building.

Crane Harbor Acquisition Corp. operates as a blank check company. It was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded on January 2, 2025 and is headquartered in Philadelphia, PA.

Crane Harbor Acquisition Corp. - Ordinary Shares - Class A

Crane Harbor Acquisition Corp.

Crane Harbor Acquisition Corp. is trending as shareholders recently approved its merger with Xanadu Quantum Technologies, a milestone expected to establish the first publicly traded photonic quantum computing company under the ticker XNDU. Community discussion is heavily focused on the deal's potential for a low-float short-term squeeze, strategic partnerships with major tech industry leaders, and potential government funding support.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Larimar Therapeutics (NASDAQ:LRMR) Stock Price Up 8.2% After Analyst Upgrade

Larimar Therapeutics (NASDAQ:LRMR) Stock Price Up 8.2% After Analyst Upgrade...

Wedbush Increases Larimar Therapeutics (NASDAQ:LRMR) Price Target to $13.00

Wedbush lifted their price target on shares of Larimar Therapeutics from $12.00 to $13.00 and gave the stock an "outperform" rating in a research note on Friday...

Larimar Therapeutics, Inc. (NASDAQ:LRMR) Sees Significant Decrease in Short Interest

Larimar Therapeutics, Inc. (NASDAQ:LRMR - Get Free Report) saw a significant decline in short interest during the month of February. As of February 27th, there was short interest totaling 7,692,689...

Mangrove Partners IM LLC Sells 327,997 Shares of Larimar Therapeutics, Inc. $LRMR

Mangrove Partners IM LLC decreased its position in Larimar Therapeutics, Inc. (NASDAQ:LRMR - Free Report) by 42.6% during the third quarter, according to its most recent disclosure with the...

Investors Purchase Large Volume of Larimar Therapeutics Call Options (NASDAQ:LRMR)

Larimar Therapeutics, Inc. (NASDAQ:LRMR - Get Free Report) was the recipient of some unusual options trading activity on Friday. Traders acquired 3,011 call options on the stock. This is an increase...

Larimar Therapeutics (NASDAQ:LRMR) Stock Price Down 8% - Should You Sell?

Larimar Therapeutics (NASDAQ:LRMR) Trading Down 8% - Here's Why...

LRMR Stock on the Move: What Sparked the 55% Jump in the Past Month?

Larimar's stock jumps 55% in a month after the FDA grants breakthrough therapy status to its FA drug nomlabofusp and backs a potential accelerated path.

Larimar Therapeutics (NASDAQ:LRMR) Price Target Raised to $12.00

Wedbush lifted their price target on shares of Larimar Therapeutics from $11.00 to $12.00 and gave the stock an "outperform" rating in a research note on Tuesday...

James Flynn Acquires 5,000,000 Shares of Larimar Therapeutics (NASDAQ:LRMR) Stock

Larimar Therapeutics, Inc. (NASDAQ:LRMR - Get Free Report) Director James Flynn acquired 5,000,000 shares of Larimar Therapeutics stock in a transaction on Friday, February 27th. The shares were...

What is Lifesci Capital's Estimate for LRMR FY2025 Earnings?

Larimar Therapeutics, Inc. (NASDAQ:LRMR - Free Report) - Equities researchers at Lifesci Capital issued their FY2025 EPS estimates for Larimar Therapeutics in a note issued to investors on Tuesday...

Larimar Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on developing treatments for patients suffering from complex rare diseases using a novel cell penetrating peptide technology platform. It also engages in the research, development, and commercialization of novel therapeutics for mitochondrial disorders and Friedreich's ataxia. The company was founded in 2005 and is headquartered in Bala Cynwyd, PA.

Current Price	$4.49
Prev Close	$4.47
Open	$4.52
Dividend Yield	0.00%
50-Day Moving Average	$3.96
Beta	1.61
Avg. Volume	9.57M
PE Ratio	-2.03

52-Week High	$6.42
52-Week Low	$1.61
Market Capitalization	$466.43M
EPS (Annual)	-$2.27
Price to Book	4.78
Revenue Per Employee	$0.00

LRMR
Larimar Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest LRMR News

LRMRLarimar Therapeutics Inc